Concepedia
Statistics
Publications
4
Citations
205
H-Index
Active since
2017
Affiliations
Yonsei University(Current)
Catholic University of Korea
Jeuk (South Korea)
Hari Kang is an author at Yonsei University specializing in molecular oncology, oncology, and medicine.
Publications per year
2017–2025
Oncogenic BRAF fusions in mucosal melanomas activate the MAPK pathway and are sensitive to MEK/PI3K inhibition or MEK/CDK4/6 inhibition
Hyo Song Kim, Minkyu Jung, Hari Kang et al. · Oncogene · 2017 · 95 citations · Full text
Medicine, Molecular Genetics, Oncology +15
Co-clinical trials demonstrate predictive biomarkers for dovitinib, an FGFR inhibitor, in lung squamous cell carcinoma
Hye Ryun Kim, Hari Kang, Hyo Sup Shim et al. · Annals of Oncology · 2017 · 56 citations · Full text
Medicine, Oncology, Pharmacology +14
ERK-dependent IL-6 autocrine signaling mediates adaptive resistance to pan-PI3K inhibitor BKM120 in head and neck squamous cell carcinoma
Mi Ran Yun, Hyantae Choi, Hari Kang et al. · Oncogene · 2017 · 35 citations · Full text
Medicine, Cancer Biology, Oncology +15
Human Activity Recognition Through Augmented WiFi CSI Signals by Lightweight Attention-GRU
Hari Kang, Donghyun Kim, Kar‐Ann Toh · Sensors · 2025 · 19 citations · Full text
Computing, Computer Science, Computer Vision +16
1–4 of 4